24 Juni 2019 08:00 AM Eastern Daylight Time

BUSINESS WIRE

SpeeDx announce a collaborative agreement with GSK to supply tests and technology

In voller Größe anschauen

Opens in new window

Download-Formate

Volle Größe JPEG, 5536x1591, 474.0 KB
Klein JPEG, 480x138, 28.2 KB
Vorschau im JPEG-Format JPEG, 144x41, 5.3 KB
Kleinbild im JPEG-Format JPEG, 120x34, 4.3 KB

Smart Multimedia-Galerie

“SpeeDx has a demonstrated commitment to improve patient care, and our tests currently used in clinical practice are supporting Resistance Guided Therapy, positively impacting cure rates and helping to minimise the spread of antimicrobial resistant infections.” Colin Denver, SpeeDx CEO. (Photo: Business Wire)

“SpeeDx has a demonstrated commitment to improve patient care, and our tests currently used in clinical practice are supporting Resistance Guided Therapy, positively impacting cure rates and helping to minimise the spread of antimicrobial resistant infections.” Colin Denver, SpeeDx CEO. (Photo: Business Wire)

View and Share Foto

http://www.businesswire.de/multimedia/de/20190624005302/en/4590660/SpeeDx-announce-a-collaborative-agreement-with-GSK-to-supply-tests-and-technology

Share

E-Mail

Alle Nachrichten | Nachrichten mit Fotos & Multimedia > Pressemitteilung: SpeeDx announce a collaborative agreement with ...

Weitere Business Wire-Websites